Skip to main content

Sub menu

News and Community
About us

Search

Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

You are here

Home
Guidance and resources
Sponsors

Generic Partners Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (66)
Prescription medicine registration (21)
ARTG (4)
Australian Public Assessment Report (AusPAR) (1)

Date

2022 (38)
2021 (6)
2020 (5)
2019 (22)
2018 (14)
2017 (6)
2016 (1)

Results for "[search-keyword]"

Search

Sponsor content

92 result(s) found, displaying 1 to 10

NOXICID TABS HEARTBURN RELIEF esomeprazole 20 mg (as magnesium trihydrate) enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

2 December 2022

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
ESOMEPRAZOLE GPPL HEARTBURN RELIEF 20 mg esomeprazole 20 mg (as esomeprazole magnesium) enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

2 December 2022

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
NOXICID TABS HEARTBURN RELIEF esomeprazole 20 mg (as esomeprazole magnesium) enteric coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

2 December 2022

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
ESOMEPRAZOLE AMNEAL 20 mg esomeprazole (as esomeprazole magnesium) enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

2 December 2022

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
ESOMEPRAZOLE AMN 20 mg esomeprazole (as esomeprazole magnesium) enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

2 December 2022

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
NEXPRAZOLE esomeprazole (as magnesium trihydrate) 20mg enteric coated tablet bottle Cancelled under Section 30(1)(c) of the Act

2 December 2022

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
ESOMEPRAZOLE GxP esomeprazole (as magnesium trihydrate) 20mg tablet bottle Cancelled under Section 30(1)(c) of the Act

2 December 2022

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
ESOMEPRAZOLE GPPL esomeprazole (as magnesium trihydrate) 40mg tablet bottle Cancelled under Section 30(1)(c) of the Act

2 December 2022

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
ESOMEPRAZOLE GPPL esomeprazole (as magnesium trihydrate) 20mg tablet bottle Cancelled under Section 30(1)(c) of the Act

2 December 2022

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
ESOMEPRAZOLE AN esomeprazole (as magnesium trihydrate) 20mg tablet bottle Cancelled under Section 30(1)(c) of the Act

2 December 2022

Cancellation by sponsor

Requested by Generic Partners Pty Ltd

Pages

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia